The great thing with investing is letting your research take you to interesting and new areas. I've been looking at fish stocks (pun intended) for longer than any sane person probably should.🤪
Here's a primer on the #ASX aquaculture sub-sub-sub-industry. 👇
Aquaculture is farmed fish or seafood. It's been around for millennia (for the history buffs, check the link below).
Interestingly agriculture went through green and blue revolutions post 1970s, and aquaculture arguably is going through that now. alimentarium.org/en/knowledge/h…
The Australian fisheries as a sector isn't really expected to grow much at all according to ABARES ...
.. but what can get missed in this is the displacement of wild caught / unsustainable fishing practices with intensive fish farming and aquaculture. 🎣
If we look at intensive poultry farming, you notice pretty quickly that the farms are near urban centres. Essentially, the cost of transporting feed is less than that of transporting birds.
So what?
Well for companies like Inghams $ING $ING.AX they operate in a mature market where volume growth approximates population growth.
Essentially, they can't easily find export markets, they need to look at value adding / processing or new verticals (turkey, feeds, etc).
Aquaculture is different. Fish farms are located where the growing conditions are best, and then the fish are transported to where the consumers are.
You can see from Rabobanks clear map below the international trade flows of aquaculture produce.
Demand for fish varies based on cultural and consumer habits. As many would expect, consumption per capita and on a total volume basis is substantially more in Asia.
As wealth and population continues to grow in Asia, this will drive even more demand. Similarly, we are seeing shifting preferences towards fish in places likes Aus, US, Europe, and elsewhere.
So we should see:
🐟Growing demand for fish consumption
🐟Aquaculture replacing wild caught fish
🐟Increased export demand
The total market cap of aquaculture on the ASX is $1.7bn. There's not a single company in the ASX200 (Tassal fell out earlier this year), and only 5 companies have an MC greater than $100m.
When you look at the revenue though, you see not all fish are created equally.
In fact, Murray Cod Australia with 12% of the market cap has only 1% of the revenue. That's a lot of growth baked in. 🐡
But the real kicker is looking at operating EBITDA.
Clearly Tassal stands out, and Huon is doing it's bit. But what happened to Murray Cod or Seafarms (that's minus 7%, come on $MSFT you've had years to work out negative pie chart in excel).
With Covid impacting on the markets, you may think the above is an unfair characterisation. Well, let's look at PEAK EBITDA (the best result any company has ever achieved).
Tassal is still FY20, and FY21 will be more; Seafarms -7% was the best result (negative people!)
Tassal will be reporting on 18 August 2021, so we can come back to that then. For those interested in why I'm long $TGR, you can see the link below.
Huon is also a salmon producer, but has higher cost of production than TGR with greater export exposure. They've got great assets, and there is a potential asset play /takeover bid.
But with forecast FY21 EV/EBITDA=40, I find these assets a bit rich. I'll leave it for Twiggy
Murray Cod Australia $MCA $MCA.AX has a market cap now of $200m, but in May '21 it was $300m with $4m of sales.
Production actually declined in FY21 vs FY20; margins are low as people only pay $20/kg for cod vs salmon ($25), prawns ($30), etc. Nice packaging though.
NZ King Salmon $NZK $NZK.AX has premium sockeye salmon for restaurants, half in US and half in NZ. It's good! 👍
But, "troubling" times for NZK again in FY21 due to poor growing season, while revenue has flatlined/declined for 4-5yrs. Covid didn't help with -40% revs.
Seafarms $SFG $SFG.AX is a prawn farming entity based in the top-end - you may have heard of "Project Sea Dragon" with billion dollar price tags, politicians kissing baby prawns (fingerlings), and promises that in 8 simple stages it'll be producing 180,000tonnes!
Meanwhile in the real world, if they meet their target of 900t they will have added +300t or 50% since 2014 and really remain quite far away from their 6,000t target which has no defined date.
Yet their marketing continues to reference 180,000t visions. 🤷
Further, the cost of production exceeds their revenue, so they have negative operating EBITDA and have so for years. There's no clear pathway for profitability, only more capital raises.
P.S. TGR will expand to 4000t prawns this year, with $4-6/kg operating EBITDA. 🎯
Clean Seas Tuna $CSS $CSS.AX produces yellowfin tuna (lighter grade than bluefin, less flavoursome but still used in sushi).
They produce 3k tonnes, and have plans in the short term for 10kt and in the long term 30kt. Operationally, this may be possible.
Covid really squeezed them at a bad time. But if things normalise and they hit 10kt scale, they can earn $35m operating EBITDA and $10m EBIT on $66m EV.
Hmm, we may need a deep dive here! 🤔
Ocean Grown Abalone $OGA has cash in the bank, is producing 80t with plans for 600t in nearish future, is at bottom-cycle abalone prices while not burning much cash, and trades at EV/EBITDA of 5.4.
If anyone knows about future trends in global abalone prices, let's talk! 🤫
If you enjoyed this, bash the like / retweet / follow buttons.
A deep dive per week is my commitment to FinTwit.
Questions and feedback always welcome. DYOR.
Disclaimer, I'm long TGR.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Angel Seafood $AS1 $AS1.AX is the largest oyster producer in Coffin Bay, making news for all the wrong reasons. A real microcap seeking to build scale, is now the time to swim against the tide? 🦪
Let’s take a deep dive. 👇
1. Investment thesis: Fast Grower.
✅Strong market for oysters
✅Revenue ramping up
✅CAPEX pulling back
✅Biomass in place for scaling
✅Skin in the game
🚨Food poisoning / sales suspension
2. Recently I looked at East 33 $E33 as an oyster play – sorry folks, it was a ruse!
That was my competitor research on Angel, which has taken a lot longer to get my head around due to the lack of information available.
East 33 $E33 $E33.AX is a premium Sydney Rock Oyster company that recently IPO’d. Substantive performance rights for management with a colourful history will likely drive a debt-fueled acquisition binge and short term shareholder returns.
Let’s take a deep dive. 👇
1. Investment thesis: Special situation.
✅Fast top-line growth driven by acquisitions.
✅Strong market conditions.
🚩Performance incentives for EBIT and share price growth.
🚩Debt financed.
🚩History of poor management.
2. East 33 farms native Sydney Rock Oysters – a premium product.
Vertically integrated, they have an export approved facility, export certificate, 195ha of farming licenses, and a nursery.
Costa Group Holdings $CGC $CGC.AX is Australia’s largest grower, packer and marketer of fresh fruit and vegetables. If you like your berries, mushrooms, tomatoes, avocados and citrus, maybe you’ll like the taste of Costa Group.
Let’s take a deep dive. 👇
1. Investment thesis:
✅Stalwart.
✅Market leading position in multiple growing consumer staples lines.
✅International expansion.
✅Generating decent operating free cash flow.
✅Trading at 52 week lows.
🚩CAPEX requirements
🚩Margins & growth rates.
2. Costa’s has grown over the years by modernising fruit and veg growing – bringing new varieties, 52-week availability to supermarkets, economies of scale, and locations near to major urban centres.
Wake up to find out Europe is in a gas crisis, Barnaby Joyce is worried about burping cows, and now you find your portfolio is underweight #seaweed ? Me too.
Let's take a look at 'Australian Seaweed As A Megatrend' 👇
1. Investment Thesis: Early stage investing in seaweed as a nascent industry with significant growth potential due to multiple mega trends (climate change, organic fertilizers, food security, and biopharma); moving from research into commercialisation.
2. What is seaweed?
Seaweed biomass can be used for an array of possible uses including food, animal feed, high-value pharmaceutical/ industrial compounds, biofuels, and fertilisers. It's grown in water, and has environmental benefits.
Rubicon Water Limited $RWL $RWL.AX is an irrigation efficiency hardware and software company. They've built out from Australia into US, Europe and recently China and India - big markets. After successfully IPO'ing this month, they're up 75%.
Genex $GNX $GNX.AX is a renewable energy developer with a focus on firming through pumped hydro and batteries. After 6yrs in the sin bin for epic delays, what's changed?
@ElephantCapita2 will also share his technical analysis to answer 'why now?'
Let’s take a deep dive.👇
1. Investment thesis: Turnaround / Asset play.
A high CAPEX company, in a growing sector, potential takeover target, progressed through multiple de-risking events, but due to failures since IPO in 2015 its priced markedly below fair value.
Potential to become a stalwart?🤷
2. Growing demand for renewables.
There’s a long tailwind of renewable energy growth, both as total consumption increases and renewables replace fossils. Wind, solar and other (inc. bioenergy) are growing, and Genex is positioning itself in that super fast growing space.